155 related articles for article (PubMed ID: 34738601)
1. The metastatic lymph node ratio is a better prognostic factor than the number of metastatic limph node after curative resection for gastric cancer.
Giuffrida M; Viani L; Iapichino GG; Cozzani F; Dell'Abate P; Del Rio P
Acta Biomed; 2021 Nov; 92(5):e2021284. PubMed ID: 34738601
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis.
Ergenç M; Uprak TK; Akın Mİ; Hekimoğlu EE; Çelikel ÇA; Yeğen C
BMC Surg; 2023 Aug; 23(1):220. PubMed ID: 37550669
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.
Hou Y; Wang X; Chen J
World J Surg Oncol; 2018 Oct; 16(1):198. PubMed ID: 30286762
[TBL] [Abstract][Full Text] [Related]
4. The lymph node ratio as a prognostic factor for gastric cancer.
Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K
Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
7. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of prognostic model based on extragastric lymph nodes metastasis and lymph node ratio in node-positive gastric cancer: a retrospective cohort study based on a multicenter database.
Zeng Y; Cai F; Wang P; Wang X; Liu Y; Zhang L; Zhang R; Chen L; Liang H; Ye Z; Deng J
Int J Surg; 2023 Apr; 109(4):794-804. PubMed ID: 36999785
[TBL] [Abstract][Full Text] [Related]
9. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients.
Fukuda N; Sugiyama Y; Midorikawa A; Mushiake H
World J Surg; 2009 Nov; 33(11):2378-82. PubMed ID: 19760318
[TBL] [Abstract][Full Text] [Related]
11. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Komori K; Tamagawa A; Nakazano M; Hara K; Hashimoto I; Tamagawa H; Segami K; Maezawa Y; Kano K; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(2):994-1000. PubMed ID: 35241561
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer.
Gulmez S; Senger AS; Uzun O; Omeroglu S; Ofluoglu C; Sert ZO; Oz A; Polat E; Duman M
Niger J Clin Pract; 2021 Nov; 24(11):1602-1608. PubMed ID: 34782497
[TBL] [Abstract][Full Text] [Related]
13. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.
Maduekwe UN; Lauwers GY; Fernandez-Del-Castillo C; Berger DL; Ferguson CM; Rattner DW; Yoon SS
Ann Surg Oncol; 2010 May; 17(5):1267-77. PubMed ID: 20099040
[TBL] [Abstract][Full Text] [Related]
14. Accurate Risk Stratification of Patients with Node-Positive Gastric Cancer by Lymph Node Ratio.
Nakamura S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
World J Surg; 2020 Dec; 44(12):4184-4192. PubMed ID: 32892273
[TBL] [Abstract][Full Text] [Related]
15. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
[TBL] [Abstract][Full Text] [Related]
16. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
Baqar AR; Wilkins S; Wang W; Oliva K; McMurrick P
BMC Cancer; 2020 Aug; 20(1):762. PubMed ID: 32795292
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of metastatic lymph node ratio in gastric cancer].
A La-teng BL; Li YM; Liu CG; Wang BB; Xu HM; Chen JQ; Wang SB; Lu P
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):137-40. PubMed ID: 22368019
[TBL] [Abstract][Full Text] [Related]
19. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.
Bouliaris K; Rachiotis G; Diamantis A; Christodoulidis G; Polychronopoulou E; Tepetes K
Eur J Surg Oncol; 2017 Jul; 43(7):1350-1356. PubMed ID: 28433495
[TBL] [Abstract][Full Text] [Related]
20. Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer.
Macedo F; Sequeira H; Ladeira K; Bonito N; Viana C; Martins S
Future Oncol; 2021 Apr; 17(12):1519-1532. PubMed ID: 33626938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
